Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
1.000
-0.090 (-8.26%)
May 2, 2025, 4:00 PM EDT - Market closed
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $40.34 million as of May 2, 2025. Its market cap has decreased by -59.03% in one year.
Market Cap
40.34M
Enterprise Value
-61.87M
1-Year Change
-59.03%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $40.34M, a decrease of -93.03%. That is a compound annual growth rate of -48.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2025 | 43.97M | -9.52% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.09B |
| Johnson & Johnson | 371.64B |
| UnitedHealth Group | 364.71B |
| AbbVie | 342.01B |
| Novo Nordisk | 298.09B |
| Abbott Laboratories | 227.71B |
| Novartis AG | 223.05B |
| AstraZeneca | 218.59B |